从原生受体过渡到合成受体:扩大T细胞工程和超越
Cellular & molecular immunology
|June 6, 2025
概括
使用本地和合成受体的工程T细胞,提供了超越癌症的新疗法. 这些T细胞工程的进步有望为各种疾病提供更广泛的应用,并改善患者的治疗结果.
科学领域:
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
- 分子生物学分子生物学
背景情况:
- T细胞免疫疗法已经取得了显著的进步,从天然的T细胞受体 (TCR) 转向人工合成受体.
- 了解本地TCR生物学对于设计具有增强治疗潜力的下一代合成受体至关重要.
研究的目的:
- 审查T细胞受体的工程策略,包括原生和合成设计.
- 为了比较仿真抗原受体 (CARs) 和TCR类合成受体在特异性,有效性和安全性方面.
- 探索基因编辑技术和先进的策略,用于更广泛的工程T细胞的治疗应用.
主要方法:
- 关于T细胞受体工程的当前文献的综述.
- 不同合成受体设计的比较分析 (CARs与TCR类).
- 讨论基因编辑工具,如CRISPR-Cas9用于T细胞修饰.
主要成果:
- 合成受体,包括CAR和TCR类似的设计,提供更好的T细胞激活和治疗潜力.
- 基因编辑提高了受体性能,并降低了免疫排斥的风险.
- 工程T细胞不仅有望治疗癌症,还可以治疗病毒感染和自身免疫性疾病.
结论:
- 原生和合成T细胞受体是免疫疗法创新的关键驱动力.
- 对T细胞工程的进一步研究可以将治疗应用扩展到更广泛的疾病.
- 涉及多种免疫细胞类型的先进策略可能会导致协同和持久的治疗反应.
相关概念视频
Diversity of Antigen Receptors
822
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
822
Transduction
153
Among the three main modes of HGT—transformation, conjugation, and transduction—transduction is unique in that it is mediated by bacteriophages, or bacterial viruses.Transduction occurs in two ways. Generalized transduction occurs during the lytic cycle of a bacteriophage infection. In this process, bacteriophages infect bacterial cells, replicate within them, and ultimately cause cell lysis, releasing newly assembled virions. Occasionally, random fragments of the bacterial genome...
153
T Cell Activation and Clonal Selection
5.9K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
5.9K
B Cell Activation and Differentiation
6.9K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
6.9K
Signal Transduction: Overview
9.5K
Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
Typically, signal transduction involves three...
9.5K


